The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models

Clara Lemos, Volker Schulze, Simon J. Baumgart, Ekaterina Nevedomskaya, Tobias Heinrich, Julien Lefranc, Benjamin Bader, Clara D. Christ, Hans Briem, Lara Kuhnke, Simon J. Holton, Ulf Bömer, Philip Lienau, Franz von Nussbaum, Carl F. Nising, Marcus Bauser, Andrea Hägebarth, Dominik Mumberg, Bernard Haendler